FORMULATION DEVELOPMENT AND EVALUATION OF CALCIPOTRIOL AND PREDNICARBATE FOR TOPICAL TREATMENT OF PSORIASIS

  • Jyoti Phatangare Department of Pharmacy, Shree JJT University, Jhunjhunu, India
DOI https://doi.org/10.22270/jddt.v4i5.944

Abstract

Calcipotriol and Prednicarbate are widely used effective treatments for psoriasis vulgaris. Combined therapy is known to be superior to monotherapy, but the drug substance degrades when mixed together. The purpose of the study was to develop a formulation which combines Calcipotriol and Prednicarbate in a single vehicle hereby with optimal drug delivery into the skin. As the two substances are incompatible in aqueous and alcoholic medias, different non-aqueous formulations were prepared with suitable solvents and antioxidants. Formulations based on DPPG had no overall effect on skin permeability. However, A 5% polyoxypropylene-15 stearyl ether (PSE) formulation had a marked effect, resulted in a permeation rate comparable to the marketed combination product Diavobet (Calcipotriol and Betamethasone ointment). Thus, by using PSE as solvent, it was possible to combine Calcipotriol and Prednicarbate in a single formulation.

 

Keywords: Calcipotriol, Prednicarbate, polyoxypropylene-15 stearyl ether, psoriasis vulgaris.

Downloads

Download data is not yet available.
Statistics
400 Views | 811 Downloads
How to Cite
1.
Phatangare J. FORMULATION DEVELOPMENT AND EVALUATION OF CALCIPOTRIOL AND PREDNICARBATE FOR TOPICAL TREATMENT OF PSORIASIS. JDDT [Internet]. 14Sep.2014 [cited 27Nov.2021];4(5):109-15. Available from: http://jddtonline.info/index.php/jddt/article/view/944
Issue
Vol 4 No 5 (2014): Volume 4, Issue 5, Sep-Oct, 2014
Section
Research

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).